Ireland· IE-PA-EU/1/21/1607/004
Skytrofa 5.2 mg Powder and solvent for solution for injection
A lonapegsomatropin product containing lonapegsomatropin + somatropin, registered in Ireland by Ascendis Pharma Endocrinology Division A/S. The same ATC class is registered in 8 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Lonapegsomatropin is registered in 8 of 19 countries.
Countries holding a registration under ATC H01AC09 (lonapegsomatropin), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 5 of them publish a price we can compare per daily dose
Lonapegsomatropin · ATC H01AC09
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Polandprice
- United Statesprice
The record
At a glance
HPRA (Ireland)- Active substance
- Lonapegsomatropin + Somatropin
- Manufacturer
- Ascendis Pharma Endocrinology Division A/S
- Country
- Ireland (IE)
- ATC code
- H01AC09
- ATC class
- Lonapegsomatropin
- Defined daily dose
- 0.9 mg, P
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/21/1607/004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Lonapegsomatropin in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cbb8ec7f-8d04-4ffc-885b-be96cfe21db4 GET /v1/drugs/cbb8ec7f-8d04-4ffc-885b-be96cfe21db4?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder and solvent for solution for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"H01AC09"
],
"strength": null,
"pa_number": "EU/1/21/1607/004",
"substances": [
"Lonapegsomatropin",
"Somatropin"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "11/01/2022",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about lonapegsomatropin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.